Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 6/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10706694 | 0.72 | CHAT (0.62) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL10706687 | 0.72 | CHAT (0.62) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL10706700 | 0.72 | CHAT (0.62) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL4666033 | 0.72 | MAOB (0.43) | CHATHDAC8HDAC6 | |
| SCHEMBL10437275 | 0.70 | CHAT (0.60) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL10437274 | 0.70 | CHAT (0.60) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL3932039 | 0.70 | ALDH1A1 (0.58) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL4925730 | 0.69 | RXRA (0.53) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL29399914 | 0.68 | RXRA (0.57) | CHATHDAC8HDAC6RXRA | |
| SCHEMBL4626591 | 0.68 | RXRA (0.57) | CHATHDAC8HDAC6RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210116488-A1 | Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-04-22 | — | — | US | claimed |
| US-10405750-B2 | Nonradiative voltage-sensitive dye for imaging neuronal action potential | WASHINGTON UNIVERSITY (US) | 2019-09-10 | — | — | US | claimed |
| US-20190235002-A1 | Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2019-08-01 | — | — | US | claimed |
| US-20170268031-A1 | METHODS FOR BACTERIOPHAGE DETECTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-21 | — | — | US | claimed |
| WO-2016134469-A1 | APPARATUS FOR MEASUREMENT OF OPTICAL TRANSMISSION USING FLUORESCENCE RADIATION | ASTENJOHNSON, INC. (US) | 2016-09-01 | — | — | WO | claimed |
| US-20160242651-A1 | NONRADIATIVE VOLTAGE-SENSITIVE DYE FOR IMAGING NEURONAL ACTION POTENTIAL | WASHINGTON UNIVERSITY | 2016-08-25 | — | — | US | claimed |
| WO-2016018678-A1 | METHODS FOR BACTERIOPHAGE DETECTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-02-04 | — | — | WO | claimed |
| US-20110028837-A1 | Photodynamic-based myocardial mapping device and method | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. | 2011-02-03 | — | — | US | claimed |
| EP-2254463-A2 | PHOTODYNAMIC-BASED MYOCARDIAL MAPPING DEVICE AND METHOD | St. Jude Medical, Atrial Fibrillation Division, Inc. (US) | 2010-12-01 | — | — | EP | claimed |
| WO-2009124220-A2 | PHOTODYNAMIC-BASED MYOCARDIAL MAPPING DEVICE AND METHOD | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. (US) | 2009-10-08 | — | — | WO | claimed |
| US-20070281330-A1 | Method for Examining the Activity of Ion Channels | EVOTEC AG (DE) | 2007-12-06 | — | — | US | claimed |
| EP-1711832-A1 | METHOD FOR EXAMINING THE ACTIVITY OF ION CHANNELS | Evotec AG (DE) | 2006-10-18 | — | — | EP | claimed |
| WO-2006037226-A1 | USE OF QUANTUM DOTS FOR BIOLOGICAL LABELS AND SENSORS | MCGILL UNIVERSITY (CA) | 2006-04-13 | — | — | WO | claimed |
| WO-2005069008-A1 | METHOD FOR EXAMINING THE ACTIVITY OF ION CHANNELS | EVOTEC AG (DE) | 2005-07-28 | — | — | WO | claimed |
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIV WASHINGTON (US) | 2026-01-15 | — | — | US | disclosed |
| US-12447469-B2 | Methods and apparatus for single biological nanoparticle analysis | UNIVERSITY OF WASHINGTON (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250101504-A1 | METHODS OF MEASURING MISLOCALIZATION OF AN ANALYTE | 10X GENOMICS, INC. | 2025-03-27 | — | — | US | disclosed |
| US-20050153128-A1 | Product packaging including digital data | SELINFREUND RICHARD H (US) | 2005-07-14 | — | — | US | disclosed |
| US-6472163-B1 | >100 REGIONS WITH >/= A BIOLOGICAL CELL ON A CONTINUOUS BASE AT AVERAGE DENSITY OF >/=10 REGIONS PER SQUARE CM, A REACTION RESULTS IN AN OPTICALLY DETECTABLE SIGNAL CHANGE OVER TIME, AUTOMATICALLY MONITORING CHANGES TO INDICATE DESIRED SIGNAL | KAIROS SCIENTIFIC, INC. | 2002-10-29 | — | — | US | disclosed |
| WO-2001066788-A2 | COLORIMETRIC MUTAGENIZED ENZYME SCREENING IN MICROCOLONIES | KAIROS SCIENTIFIC, INC. (US) | 2001-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | CD63, SELL, LAMP2 | CHAT 1287/4885HDAC8 3392/4885HDAC6 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.